Figure 2
(A,B) The B7-H3 (CD276) mRNA expression is associated with a worse OS (A) and RFS (B) in breast cancer patients. (C,D) The CTLA4 mRNA expression is associated with a better OS (C) and RFS (D) in breast cancer patients. (E,F) The TIGIT mRNA expression is associated with a better OS (E) and RFS (F) in breast cancer patients.
The correlation between inhibitory immune checkpoint genes mRNA expression and prognosis of breast cancer patients

(A,B) The B7-H3 (CD276) mRNA expression is associated with a worse OS (A) and RFS (B) in breast cancer patients. (C,D) The CTLA4 mRNA expression is associated with a better OS (C) and RFS (D) in breast cancer patients. (E,F) The TIGIT mRNA expression is associated with a better OS (E) and RFS (F) in breast cancer patients.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept